SCANPHARM A/S: Financial statements 2016
CVR: 16279099
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 19,626,649 and a net result of DKK 1,267,088 compared with DKK 715,522 the year before. That is a decrease of 4% compared with the year before. Equity in the 2016 report amounted to DKK 12,971,605. The solvency ratio was 38.8%. The company had 42 employees in the financial year.
- Gross Profit
- DKK 19,626,649
- Profit/Loss
- DKK 1,267,088
- Equity
- DKK 12,971,605
- Total Assets
- DKK 33,401,535
- Employees
- 42
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 19.6 mio. | 1.3 mio. | 13 mio. | 42 |
| 2015 | - | 20.4 mio. | 716 t. | 11.7 mio. | 42 |
| 2014 | - | 20.8 mio. | 431 t. | 11 mio. | - |
| 2013 | - | 20.9 mio. | 400 t. | 10.6 mio. | - |
Official annual report
Find more companies like SCANPHARM A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
SCANPHARM A/S has published its annual report for 2015. Gross profit came to DKK 20,446,816, and the net result was DKK 715,522.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees (2018). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.